Healthy Skepticism Library item: 2551
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Mintzes B, Baraldi R.
Direct to Consumer Prescription Drug Advertising: When preventing harm is no longer a priority
: DES Action Canada 2001;
http://web.archive.org/web/20011217054640/http://www.web.net/~desact/anglais/anglais.html
Abstract:
This pamphlet outlines Canadian regulations around DTCA and provides examples of how drug companies are getting around the rules. The pamphlet also criticizes the weak enforcement by Health Canada of existing rules. Recommendations for strengthening the ban on DTCA are advanced.
Keywords:
*analysis
Canada
DTCA
direct-to-consumer advertising
quality of information
Health Canada
Evista
Diane-35
raloxifene
Berlex
Eli Lilly
marketing strategies
guidelines, discussion of
raloxifene
EVALUATION OF PROMOTION: DIRECT-TO-CONSUMER ADVERTISING
IMAGES IN PROMOTION: WOMEN
REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION
